These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 12420877

  • 1. Synthesis and anti-hIV activity of 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole structurally-related 1,2-substituted benzimidazoles.
    Rao A, Chimirri A, De Clercq E, Monforte AM, Monforte P, Pannecouque C, Zappalà M.
    Farmaco; 2002 Oct; 57(10):819-23. PubMed ID: 12420877
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and biological activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors.
    Chimirri A, Grasso S, Monforte P, Rao A, Zappalà M, Monforte AM, Pannecouque C, Witvrouw M, Balzarini J, De Clercq E.
    Antivir Chem Chemother; 1999 Jul; 10(4):211-7. PubMed ID: 10480739
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles.
    Roth T, Morningstar ML, Boyer PL, Hughes SH, Buckheit RW, Michejda CJ.
    J Med Chem; 1997 Dec 19; 40(26):4199-207. PubMed ID: 9435891
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, structure and in vitro anti-human immunodeficiency virus activity of novel 3-methyl-1H,3H-thiazolo[3,4-a]benzimidazoles.
    Chimirri A, Grasso S, Monforte AM, Monforte P, Rao A, Zappalà M, Bruno G, Nicolò F, Pannecouque C, Witvrouw M, De Clercq E.
    Antivir Chem Chemother; 1998 Sep 19; 9(5):431-8. PubMed ID: 9875396
    [Abstract] [Full Text] [Related]

  • 5. Synthesis, biological activity, pharmacokinetic properties and molecular modelling studies of novel 1H,3H-oxazolo[3,4-a]benzimidazoles: non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Chimirri A, Monforte P, Rao A, Zappalà M, Monforte AM, De Sarro G, Pannecouque C, Witvrouw M, Balzarini J, De Clercq E.
    Antivir Chem Chemother; 2001 May 19; 12(3):169-74. PubMed ID: 12959325
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents.
    Barreca ML, Balzarini J, Chimirri A, De Clercq E, De Luca L, Höltje HD, Höltje M, Monforte AM, Monforte P, Pannecouque C, Rao A, Zappalà M.
    J Med Chem; 2002 Nov 21; 45(24):5410-3. PubMed ID: 12431069
    [Abstract] [Full Text] [Related]

  • 7. Nonnucleoside HIV-1 reverse transcriptase inhibitors; part 3. Synthesis and antiviral activity of 5-alkyl-2-[(aryl and alkyloxyl-carbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones.
    He Y, Chen F, Yu X, Wang Y, De Clercq E, Balzarini J, Pannecouque C.
    Bioorg Chem; 2004 Dec 21; 32(6):536-48. PubMed ID: 15530994
    [Abstract] [Full Text] [Related]

  • 8. Design and synthesis of N₁-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Monforte AM, Ferro S, De Luca L, Lo Surdo G, Morreale F, Pannecouque C, Balzarini J, Chimirri A.
    Bioorg Med Chem; 2014 Feb 15; 22(4):1459-67. PubMed ID: 24457088
    [Abstract] [Full Text] [Related]

  • 9. Anti-HIV agents: design and discovery of new potent RT inhibitors.
    Barreca ML, Chimirri A, De Clercq E, De Luca L, Monforte AM, Monforte P, Rao A, Zappalà M.
    Farmaco; 2003 Mar 15; 58(3):259-63. PubMed ID: 12620421
    [Abstract] [Full Text] [Related]

  • 10. [Design, synthesis and biologic evaluation of diarylbenzimidazole derivatives as novel HIV-1 non-nucleoside reverse transcriptase inhibitors].
    Qin BJ, Zhou T, Lu H, Jiang SB, Xie L.
    Yao Xue Xue Bao; 2009 Nov 15; 44(11):1233-43. PubMed ID: 21355324
    [Abstract] [Full Text] [Related]

  • 11. Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitors.
    Monforte AM, Rao A, Logoteta P, Ferro S, De Luca L, Barreca ML, Iraci N, Maga G, De Clercq E, Pannecouque C, Chimirri A.
    Bioorg Med Chem; 2008 Aug 01; 16(15):7429-35. PubMed ID: 18585918
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents.
    Monforte AM, Logoteta P, Ferro S, De Luca L, Iraci N, Maga G, Clercq ED, Pannecouque C, Chimirri A.
    Bioorg Med Chem; 2009 Aug 15; 17(16):5962-7. PubMed ID: 19616956
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, anti-HIV-1 activity, and modeling studies of N-3 Boc TSAO compound.
    Tomassi C, Nguyen VN, Marco-Contelles J, Balzarini J, Pannecouque C, De Clercq E, Soriano E, Postel D.
    Bioorg Med Chem Lett; 2008 Apr 01; 18(7):2277-81. PubMed ID: 18353641
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nitroimidazoles. V. Synthesis and anti-HIV evaluation of new 5-substituted piperazinyl-4-nitroimidazole derivatives.
    Al-Soud YA, Al-Masoudi NA, Hassan HG, De Clercq E, Pannecouque C.
    Acta Pharm; 2007 Dec 01; 57(4):379-93. PubMed ID: 18165184
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
    Wu B, Kuhen K, Ngoc Nguyen T, Ellis D, Anaclerio B, He X, Yang K, Karanewsky D, Yin H, Wolff K, Bieza K, Caldwell J, He Y.
    Bioorg Med Chem Lett; 2006 Jul 01; 16(13):3430-3. PubMed ID: 16632349
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.